Effect of antiepilepsy drug therapy on ventricular function in children with epilepsy: a tissue Doppler imaging study

Ayse Esin Kibar1, Olcay Unver, Mehmet Burhan Oflaz

  • 1Department of Pediatric Cardiology, Mersin Women's and Children's Hospital, Güneykent, Mersin, Turkey, dreseresin@yahoo.com.

Pediatric Cardiology
|August 15, 2013
PubMed

Insights

Antiepilepsy drugs (AEDs) may cause subclinical cardiac dysfunction in children with epilepsy. Tissue Doppler imaging (TDI) can detect early signs of ventricular dysfunction in these patients.

Area of Science:

  • Cardiology
  • Pediatric Neurology
  • Pharmacology

Background:

  • Sudden unexpected death in epilepsy patients can be linked to impaired cardiac function.
  • Antiepilepsy drugs (AEDs) are crucial for managing epilepsy but may have cardiac implications.

Purpose of the Study:

  • To investigate the cardiac effects of AEDs in pediatric epileptic patients.
  • To assess cardiac function using standard and tissue Doppler imaging (TDI) echocardiography.

Main Methods:

  • A prospective cross-sectional study involving 52 epileptic children on AEDs and 36 healthy controls.
  • Echocardiography, including standard and TDI, was used to evaluate cardiac parameters.

Main Results:

  • Epileptic children showed increased left ventricular dimensions and mass, with preserved ejection fraction.
  • TDI revealed impaired diastolic function, including increased isovolumetric relaxation time and myocardial performance index (MPI).
  • Subclinical ventricular dysfunction was detected in AED-treated children, correlating with LV mass index.

Conclusions:

  • AEDs are associated with subclinical ventricular dysfunction in pediatric epilepsy patients.
  • TDI is a valuable tool for monitoring short- and long-term cardiac effects of AEDs.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...